May 16th 2019: Cardiaccs renews ISO 13485 certificate
Cardiaccs has been ISO 13485 certified for design and development of medical devices since 2016 and our successful renewal means that we are certified for a further three years.
As we approach commercialisation we can expect that surveillance by our Notified Body will become more rigourous and frequent requireing us to investment significant time and effort into maintaining our ISO 13485 certification and deliver products of the highest quality.
February 11th 2019: Cardiaccs presents progress at UiO Oslo Life Science conference
Watch as Cardiaccs CEO, Shane West, presents our history and aspirations to the distinguished audience at UiO Life Science conference.
August 2018: Cardiaccs granted €3M in H2020 FTI funding
Aleap member, Cardiaccs, received the happy news they are the recipients of €3M in EU funding through the Horizon 2020 Fast Track to Innovation program. The funds will be used to complete clinical trials and continue product development for Cardiaccs’ sensor for continuous measurement of cardiac function. Read article in DN (Norwegian)
May 2018: Surgeons give Cardisense thumbs up
Cardiaccs has conducted qualitative interviews with 20 cardiac surgeons in US and Germany. 70% of the surgeons spontaneously reacted positively when shown concept, all indicated that it would be advantageous in their current role. This confirms that we're heading in the right direction! Read full article
October 2016: Aleap health incubator opened
The first health incubator in Norway, Aleap, officially opened on October 12th. As a member of the incubator, Cardiaccs got the opportunity to present the Cardisense technology to the His Royal Highness Crownprince Haakon, the Norwegian Minister of Health and Care Services, Bent Høie, and the Governing Mayor of Oslo, Raymond Johansen. Read more
February 28th 2019: Cardiaccs kicks off SAMBAfun EU research program
The €3M project supported by the EU H2020 funding initiative officially kicked off on Feb 28th at the Intervention Centre at Oslo University Hospital.
Cardiaccs, as the coordinator, was joined by project partners Aarhus University Hospital, Oslo Univerity Hospital, Osypka AG and German Heart Centre Berlin.
The program will accelerate development of our sensor system for intra and post operative monitoring of cardiac contractility. Follow the program on the SAMBAfun website and
We are very pleased to announce the appointment of Mr. Shane West as Chief Executive Officer effective May 1st. Shane succeeds Prof. Erik Fosse who has been CEO since founding the company in 2009. Erik will continue to play a very active role in the company as Chairman of the Board of Directors. Read full press release here
October 2017: Selected for DNB healtchare prize final
We are very proud to have been selected to the Final of the DNB Healthcare Prize 2017. The Final of the DNB Healthcare Prize 2017 will take place at the DNB Nordic Healthcare Conference 2017 and Cardiaccs is one of six companies which will get the opportunity to win the first prize of 1 million NOK. Date: 14 December. Venue: DNB in Bjørvika, Dronning Eufemiasgate 30, 0191 Oslo
June 2016: Cardiaccs granted Eurostars funding
Cardisense has been approved for funding through the Eurostars programme. We are honoured and proud to have been ranked as number 20 out of 269 eligible applications from all over Europe